Navigation Links
DuPont Chief Financial Officer Reviews Company's Accelerated Growth Plan
Date:3/20/2008

NEW YORK, March 20 /PRNewswire-FirstCall/ -- At a conference with security analysts today, DuPont (NYSE: DD) Executive Vice President & Chief Financial Officer Jeffrey L. Keefer reviewed the company's accelerated growth plan, designed to nearly double DuPont's earnings growth rate over the next three years.

"As a market-driven science company, DuPont's competitive advantage is new product innovation," Keefer said. "Our rising return from innovation and rapid growth in emerging markets are key growth drivers for us. We will continue to execute our growth strategies while maintaining financial discipline and increasing productivity gains across the company."

The actions DuPont is taking are expected to increase the company's revenue growth rate from 5 percent to about 7-9 percent per year, including 1- 2 percent from bolt-on acquisitions, Keefer said.

Based on current plans, DuPont projects it can achieve earnings per share growth of 10 percent or more, on average, between 2008 and 2010, despite anticipated declines in pharmaceutical royalties after patents expire in 2010. Keefer said the company's goal is to achieve 2010 earnings per share within a range of $4.05 to $4.30. In 2007, the company earned $3.28 per share, excluding net significant item charges of $.06 per share.

The company intends to capitalize on rising global demand for its science- based products in agriculture and safety and protection; further penetrate key markets in the world's rapidly growing geographies; and extend its productivity improvement programs. DuPont expects to generate $1.7 billion in productivity gains over the next three years by continuing efforts already under way to streamline and simplify its supply chains and business support operations.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont's filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Alexander M. Cutler Nominated for Election to DuPont Board of Directors
2. Woman Sues DuPont and Asbestos Manufacturers After Developing Mesothelioma From Exposure to Asbestos in Husbands Work Clothes
3. DuPont Strengthens Leading Biotechnology Position with Leadership Changes
4. DuPont Responds to Spelter, W.Va. Lawsuit Rulings
5. DuPont Pledges $1 Million to World Food Prize
6. DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity
7. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
8. DuPont Announces Leadership Changes
9. DuPont Opens Fluoropolymer Production Plant in China
10. DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker
11. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, ... steady since 2009, according to a Workers Compensation Research Institute (WCRI) study, a ... the North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and ...
(Date:5/23/2017)... Santa Rosa, California (PRWEB) , ... May 23, ... ... population health management (PHM) technology and a 2017 Best in KLAS category winner, ... an advantageous market position to extend and enhance its technology platform and product ...
(Date:5/23/2017)... ... , ... London, May 23, 2017: Walter Schindler, the Founder and Managing Partner ... Speaker and Contributor to a weeklong series of classes, meetings, field trips and special ... Walter Schindler and SAIL Capital have received an increasing number of ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... By all ... underway in Sonoma County. While officials call for diligence, asking homeowners to scout for ... at potential health concerns. Along with the annoying buzz of mosquitos is the buzz ...
(Date:5/23/2017)... ... May 23, 2017 , ... MedTech For ... the modern ART laboratory, to provide hands-on training utilizing cutting-edge equipment at its ... LifeLabs, a MedTech Group Purchasing vendor , will provide specialized equipment to ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
(Date:5/10/2017)... Md. , May 10, 2017 CSSi, ... solutions for the clinical research industry, is proud to ... www.CSSiEnroll.com . The new website features both enriched content ... user experience and enhances the company,s already well-established position ... industry. "After many months of hard ...
(Date:5/9/2017)... PORTLAND, Ore. , May 9, 2017 /PRNewswire/ ... company that provides technology solutions to improve the ... reported financial results for the first quarter ended ... that our products enable our customers to identify ... them to intervene before events like heart attacks ...
Breaking Medicine Technology: